Anza Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C Virus
- First Posted Date
- 2008-12-01
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- Anza Therapeutics, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT00800007
- Locations
- 🇺🇸
Advanced Clinical Research Institute, Anaheim, California, United States
🇺🇸Alamo Medical Research, San Antonio, Texas, United States
Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment
Phase 1
Terminated
- Conditions
- Malignant Epithelial MesotheliomaAdenocarcinoma of the PancreasCarcinoma, Non-Small-Cell LungAdenocarcinoma of the Ovaries
- First Posted Date
- 2008-01-03
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- Anza Therapeutics, Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT00585845
- Locations
- 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸National Cancer Institute, NCI, Bethesda, Maryland, United States
🇺🇸University of Pennsylvania Abramson Family Cancer Research Center, Philadelphia, Pennsylvania, United States
Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases
Phase 1
Completed
- Conditions
- Neoplasm MetastasisLiver NeoplasmsCarcinoma
- First Posted Date
- 2006-05-18
- Last Posted Date
- 2008-04-24
- Lead Sponsor
- Anza Therapeutics, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT00327652
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸Mary Crowley Medical Research Center, Dallas, Texas, United States
News
No news found